Two Sigma Advisers’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31K | Sell |
|
|||||
|
2025
Q1 | $121K | Sell |
|
|||||
|
2024
Q4 | $307K | Buy |
|
|||||
|
2024
Q3 | $238K | Buy |
|
|||||
|
2024
Q2 | $167K | Sell |
|
|||||
|
2024
Q1 | $542K | Sell |
|
|||||
|
2023
Q4 | $1.49M | Sell |
|
|||||
|
2023
Q3 | $1.46M | Sell |
|
|||||
|
2023
Q2 | $2.59M | Buy |
|
|||||
|
2023
Q1 | $1.91M | Sell |
|
|||||
|
2022
Q4 | $1.53M | Sell |
|
|||||
|
2022
Q3 | $5.71M | Sell |
|
|||||
|
2022
Q2 | $15.8M | Buy |
|
|||||
|
2022
Q1 | $9.9M | Buy |
|
|||||
|
2021
Q4 | $7.82M | Sell |
|
|||||
|
2021
Q3 | $14.3M | Buy |
|
|||||
|
2021
Q2 | $17.7M | Buy |
|
|||||
|
2021
Q1 | $7.72M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $85K | Sell |
|
|||||
|
2019
Q3 | $199K | Sell |
|
|||||
|
2019
Q2 | $1.36M | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $81K | Buy |
|
|||||
|
2017
Q3 | $98K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $569K | Buy |
|